AlanC, I totally agree. This is a once-in-a-lifetime opportunity for most of us, to get in on the ground floor of a company that has not one but THREE promising drugs. And any one of them would warrant a far, far higher share price.

I really do think of this as being like JAZZ. Traded at 20 cents, not too many years later 180 DOLLARS.